About Nemocnice Milosrdnych bratri
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Kowa Research Institute, Inc.
1
Clinical Trials at Nemocnice Milosrdnych bratri
During the past decade, Nemocnice Milosrdnych bratri conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
2015-11-05
2019-03-31
Completed
7,797
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Milosrdnych bratri"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Nemocnice Milosrdnych bratri
According to Clinical.Site data, the most researched conditions in "Nemocnice Milosrdnych bratri" are
"Heart Failure" (2 trials), "Dyslipidemia" (1 trials), "Type2 Diabetes" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "Nemocnice Milosrdnych bratri" in a lesser frequency.
Clinical Trials Intervention Types at Nemocnice Milosrdnych bratri
Most popular intervention types in "Nemocnice Milosrdnych bratri" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials) and "K-877" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nemocnice Milosrdnych bratri
The vast majority of trials in "Nemocnice Milosrdnych bratri" are
4 trials for "All" genders.
Clinical Trials Status at Nemocnice Milosrdnych bratri
Currently, there are NaN active trials in "Nemocnice Milosrdnych bratri".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Nemocnice Milosrdnych bratri,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Nemocnice Milosrdnych bratri, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".